Chlorolissoclimides: New inhibitors of eukaryotic protein synthesis

RNA

Volumn 12, Issue 5, 2006, Pages 717-724

  Robert, Francis ^a   Hong, Qing Gao ^a   Donia, Marwa ^c   Merrick, William C ^d   Hamann, Mark T ^c   Pelletier, Jerry ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROLISSOCLIMIDE; CYTOTOXIC AGENT; DICHLOROLISSOCLIMIDE; MESSENGER RNA; NATURAL PRODUCT; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG IDENTIFICATION; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MAMMAL CELL; MOLLUSC; PLANT CELL; PLEUROBRANCHUS FORSKALII; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RIBOSOME; RNA TRANSPORT; TRANSLATION REGULATION;

EUKARYOTA; MAMMALIA; MOLLUSCA; PLEUROBRANCHUS;

EID: 33646168916     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2346806     Document Type: Article

References (30)

1. Ahuja, D., Geiger, A., Ramanjulu, J.M., Vera, M.D., SirDeshpande, B., Pfizenmayer, A., Abazeed, M., Krosky, D.J., Beidler, D., Joullie, M.M., et al. 2000. Inhibition of protein synthesis by didemnins: Cell potency and SAR. J. Med. Chem. 43: 4212-4218.
2. Bordeleau, M.E., Matthews, J., Wojnar, J.M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., and Pelletier, J. 2005. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. 102: 10460-10465.
3. Chan, J., Khan, S.N., Harvey, I., Merrick, W., and Pelletier, J. 2004. Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA 10: 528-543.
4. Fu, X., Palomar, A.J., Hong, E.P., Schmitz, F.J., and Valeriote, F.A. 2004. Cytotoxic lissoclimide-type diterpenes from the molluscs Pleurobranchus albiguttatus and Pleurobranchus forskalii. J. Nat. Prod. 67: 1415-1418.
5. Grollman, A.P. 1967. Inhibitors of protein biosynthesis, II: Mode of action of anisomycin. J. Biol. Chem. 242: 3226-3233.
6. Hanson, J.R. 2005. Diterpenoids. Nat. Prod. Rep. 22: 594-602.
7. Heys, S.D., Park, K.G., McNurlan, M.A., Calder, A.G., Buchan, V., Blessing, K., Eremin, O., and Garlick, P.J. 1991. Measurement of tumour protein synthesis in vivo in human colorectal and breast cancer and its variability in separate biopsies from the same tumour. Clin. Sci. (Lond.) 80: 587-593.
8. Kiuchi, F., Matsuo, K., Ito, M., Qui, T.K., and Honda, G. 2004. New norditerpenoids with trypanocidal activity from Vitex trifolia. Chem. Pharm. Bull. (Tokyo) 52: 1492-1494.
9. Lorsch, J.R. and Herschlag, D. 1999. Kinetic dissection of fundamental processes of eukaryotic translation initiation in vitro. EMBO J. 18: 6705-6717.
10. Malochet-Grivois, C., Cotelle, P., Biard, J.F., Henichart, J.P., Debitus, C., Roussakis, C., and Verbist, J.F. 1991. Dichlorolissoclimide, a new cytotoxic labdane derivative from Lissoclinum voeltzkowi Michaelson (Urochordata). Tetrahedon Lett. 32: 6701-6702.
11. Malochet-Grivois, C., Roussakis, C., Robillard, N., Biard, J.F., Riou, D., Debitus, C., and Verbist, J.F. 1992. Effects in vitro of two marine substances, chlorolissoclimide and dichlorolissoclimide, on a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6). Anticancer Drug Des. 7: 493-502.
12. Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L.W., and Sonenberg, N. 2004. eIF4E - from translation to transformation. Oncogene 23: 3172-3179.
13. Novac, O., Guenier, A.S., and Pelletier, J. 2004. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res. 32: 902-915.
14. Obrig, T.G., Culp, W.J., McKeehan, W.L., and Hardesty, B. 1971. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 246: 174-181.
15. Odom, O.W., Picking, W.D., and Hardesty, B. 1990. Movement of tRNA but not the nascent peptide during peptide bond formation on ribosomes. Biochemistry 29: 10734-10744.
16. Ottenheijm, H.C. and van den Broek, L.A. 1988. The development of sparsomycin as an anti-tumour drug. Anticancer Drug Des. 2: 333-337.
17. Pestka, S. 1977. Inhibitors of protein synthesis. Academic Press, New York.
18. Pestova, T.V. and Hellen, C.U. 2003. Translation elongation after assembly of ribosomes on the cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. Genes & Dev. 17: 181-186.
19. Roussakis, C., Charrier, J., Riou, D., Biard, J.F., Malochet, C., Meflah, K., and Verbist, J.F. 1994. Chemotherapeutic inhibition of erb-B2 oncogene expression on a non-small-cell cancer line (NSCLC-N6) by marine substances. Anticancer Drug Des. 9: 119-128.
20. Sambrook, J. and Russell, D.W. 2001. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Shen, C.-C., Ni, C.-L., Huang, Y.-L., Huang, R.-L., and Chen, C.-C. 2004. Furanolabdane diterpenes from Hypoestes purpurea. J. Nat. Prod. 67: 1947-1949.
22. SirDeshpande, B.V. and Toogood, P.L. 1995. Mechanism of protein synthesis inhibition by didemnin B in vitro. Biochemistry 34: 9177-9184.
23. Svitkin, Y.V. and Sonenberg, N. 2004. An efficient system for cap- and poly(A)-dependent translation in vitro. Methods Mol. Biol. 257: 155-170.
24. Svitkin, Y.V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G., Belsham, G.J., and Sonenberg, N. 2001. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7: 382-394.
25. Uddin, M.J., Kokubo, S., Ueda, K., Suenaga, K., and Uemura, D. 2001. Haterumaimides F-I, four new cytotoxic diterpene alkaloids from an ascidian Lissoclinum species. J. Nat. Prod. 64: 1169-1173.
26. van den Broek, L.A., Lazaro, E., Zylicz, Z., Fennis, P.J., Missler, F.A., Lelieveld, P., Garzotto, M., Wagener, D.J., Ballesta, J.P., and Ottenheijm, H.C. 1989. Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: A structure-activity relationship study. J. Med. Chem. 32: 2002-2015.
27. Vazquez, D. 1979. Inhibitors of protein biosynthesis. Mol. Biol. Biochem. Biophys. 30: 1-312.
28. Waridel, P., Wolfender, J.-L., Lachavanne, J.-B., and Hostettmann, K. 2004. ent-Labdane glycosides from the aquatic plant Potamogeton lucens and analytical evaluation of the lipophilic extract constituents of various Potamogeton species. Phytochemistry 65: 945-954.
29. Wendel, H.-G., de Stanchina, E., Fridman, J.S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., and Lowe, S.W. 2004. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332-337.
30. Wurmbach, P. and Nierhaus, K.H. 1979. Codon-anticodon interaction at the ribosomal P (peptidyl-tRNA)site. Proc. Natl. Acad. Sci. 76: 2143-2147.